Carlson Capital L P Cytokinetics Inc Transaction History
Carlson Capital L P
- $617 Million
- Q2 2024
A detailed history of Carlson Capital L P transactions in Cytokinetics Inc stock. As of the latest transaction made, Carlson Capital L P holds 38,200 shares of CYTK stock, worth $1.97 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
38,200
Previous 25,000
52.8%
Holding current value
$1.97 Million
Previous $1.75 Million
18.09%
% of portfolio
0.34%
Previous 0.15%
Shares
2 transactions
Others Institutions Holding CYTK
# of Institutions
409Shares Held
126MCall Options Held
3.29MPut Options Held
2.01M-
Black Rock Inc. New York, NY14.7MShares$756 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$589 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.14MShares$419 Million0.28% of portfolio
-
Wellington Management Group LLP Boston, MA7.51MShares$387 Million0.07% of portfolio
-
State Street Corp Boston, MA6.55MShares$337 Million0.02% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.85B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...